Back to Search
Start Over
Outcomes of <scp>anti‐programmed death 1</scp> treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group <scp>multicentre real‐world</scp> analysis
- Source :
- British Journal of Haematology. 198:401-404
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Nivolumab
Medizin
Humans
Hematology
Hodgkin Disease
Subjects
Details
- ISSN :
- 13652141 and 00071048
- Volume :
- 198
- Database :
- OpenAIRE
- Journal :
- British Journal of Haematology
- Accession number :
- edsair.doi.dedup.....a31ae33cd32d1570d19e17c7b11d2a43